葛蘭素史克藥廠(GlaxoSmithKline Plc GB-GSK)、諾華集團(Novartis AG CH-NOVN)和威朗製藥國際公司(Valeant Pharmaceuticals International Inc.US-VRX)一連串行動,使這股併購潮在上週達到顛峰。阿斯特捷利康發言人艾卡-帕勒(Esra Erkal-Paler)今天接受電訪時表示不予置評。她表示,阿斯特捷利康正在檢視輝瑞的聲明,並沒有進一步說明。(譯者:中央社陳昱婷)
This entry passed through the Full-Text RSS service — if this is your content and you're reading it on someone else's site, please read the FAQ at fivefilters.org/content-only/faq.php#publishers.
You are receiving this email because you subscribed to this feed at blogtrottr.com.
留言列表